Cargando…

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation

BACKGROUND: Indiana University (IU) initiated fluorescence in situ hybridisation (FISH) methodology for Burkitt Lymphoma (BL) to advance the accuracy and speed of diagnosis in the AMPATH Reference Laboratory at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. Standard diagnostic testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Vance, Gail H, Lotodo, Teresa, Kigen, Nicholas, Stohler, Ryan, Choi, Haki, Njuguna, Festus, Moormann, Ann M, Kirwa, Erastus, Langat, Sandra, Loehrer, Patrick, Vik, Terry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129372/
https://www.ncbi.nlm.nih.gov/pubmed/37113725
http://dx.doi.org/10.3332/ecancer.2023.1505
_version_ 1785030719719866368
author Vance, Gail H
Lotodo, Teresa
Kigen, Nicholas
Stohler, Ryan
Choi, Haki
Njuguna, Festus
Moormann, Ann M
Kirwa, Erastus
Langat, Sandra
Loehrer, Patrick
Vik, Terry
author_facet Vance, Gail H
Lotodo, Teresa
Kigen, Nicholas
Stohler, Ryan
Choi, Haki
Njuguna, Festus
Moormann, Ann M
Kirwa, Erastus
Langat, Sandra
Loehrer, Patrick
Vik, Terry
author_sort Vance, Gail H
collection PubMed
description BACKGROUND: Indiana University (IU) initiated fluorescence in situ hybridisation (FISH) methodology for Burkitt Lymphoma (BL) to advance the accuracy and speed of diagnosis in the AMPATH Reference Laboratory at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. Standard diagnostic testing for BL at MTRH includes morphology of the biopsy specimen or aspirate and limited immunohistochemistry panels. METHODS: Tumour specimens from 19 children enrolled from 2016 to 2018 in a prospective study to improve the diagnosis and staging of children with suspected BL were evaluated. Touch preps from biopsy specimens or smears from fine needle aspiration were collected, stained with Giemsa and/or H&E and reviewed by pathologists to render a provisional diagnosis. Unstained slides were stored and later processed for FISH. Duplicate slides were split between two laboratories for analysis. Flow cytometry results were available for all specimens. Results from the newly established FISH laboratory in Eldoret, Kenya were cross-validated in Indianapolis, Indiana. RESULTS: Concordance studies found 18 of 19 (95%) of specimens studied yielded analysable FISH results for one or both probe sets (MYC and MYC/IGH) in both locations. There was 94% (17/18) concordance of results between the two FISH laboratories. FISH results were 100% concordant for the 16 specimens with a histopathological diagnosis of BL and two of three non-BL cases (one case no result in IU FISH lab). FISH was similarly concordant with flow cytometry for specimens with positive flow results with the exception of a nasopharyngeal tumour with positive flow results for CD10 and CD20 but was negative by FISH. The modal turn-around time for FISH testing on retrospective study specimens performed in Kenya ranged between 24 and 72 hours. CONCLUSION: FISH testing was established, and a pilot study performed, to assess the feasibility of FISH as a diagnostic tool for the determination of BL in a Kenyan paediatric population. This study supports FISH in limited resource settings to improve the accuracy and speed of diagnosis of BL in Africa.
format Online
Article
Text
id pubmed-10129372
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cancer Intelligence
record_format MEDLINE/PubMed
spelling pubmed-101293722023-04-26 Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation Vance, Gail H Lotodo, Teresa Kigen, Nicholas Stohler, Ryan Choi, Haki Njuguna, Festus Moormann, Ann M Kirwa, Erastus Langat, Sandra Loehrer, Patrick Vik, Terry Ecancermedicalscience Short Communication BACKGROUND: Indiana University (IU) initiated fluorescence in situ hybridisation (FISH) methodology for Burkitt Lymphoma (BL) to advance the accuracy and speed of diagnosis in the AMPATH Reference Laboratory at Moi Teaching and Referral Hospital (MTRH) in Eldoret, Kenya. Standard diagnostic testing for BL at MTRH includes morphology of the biopsy specimen or aspirate and limited immunohistochemistry panels. METHODS: Tumour specimens from 19 children enrolled from 2016 to 2018 in a prospective study to improve the diagnosis and staging of children with suspected BL were evaluated. Touch preps from biopsy specimens or smears from fine needle aspiration were collected, stained with Giemsa and/or H&E and reviewed by pathologists to render a provisional diagnosis. Unstained slides were stored and later processed for FISH. Duplicate slides were split between two laboratories for analysis. Flow cytometry results were available for all specimens. Results from the newly established FISH laboratory in Eldoret, Kenya were cross-validated in Indianapolis, Indiana. RESULTS: Concordance studies found 18 of 19 (95%) of specimens studied yielded analysable FISH results for one or both probe sets (MYC and MYC/IGH) in both locations. There was 94% (17/18) concordance of results between the two FISH laboratories. FISH results were 100% concordant for the 16 specimens with a histopathological diagnosis of BL and two of three non-BL cases (one case no result in IU FISH lab). FISH was similarly concordant with flow cytometry for specimens with positive flow results with the exception of a nasopharyngeal tumour with positive flow results for CD10 and CD20 but was negative by FISH. The modal turn-around time for FISH testing on retrospective study specimens performed in Kenya ranged between 24 and 72 hours. CONCLUSION: FISH testing was established, and a pilot study performed, to assess the feasibility of FISH as a diagnostic tool for the determination of BL in a Kenyan paediatric population. This study supports FISH in limited resource settings to improve the accuracy and speed of diagnosis of BL in Africa. Cancer Intelligence 2023-02-08 /pmc/articles/PMC10129372/ /pubmed/37113725 http://dx.doi.org/10.3332/ecancer.2023.1505 Text en © the authors; licensee ecancermedicalscience. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Vance, Gail H
Lotodo, Teresa
Kigen, Nicholas
Stohler, Ryan
Choi, Haki
Njuguna, Festus
Moormann, Ann M
Kirwa, Erastus
Langat, Sandra
Loehrer, Patrick
Vik, Terry
Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
title Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
title_full Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
title_fullStr Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
title_full_unstemmed Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
title_short Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
title_sort improvement of diagnosis in children with burkitt lymphoma in kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for myc and the myc/igh translocation
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129372/
https://www.ncbi.nlm.nih.gov/pubmed/37113725
http://dx.doi.org/10.3332/ecancer.2023.1505
work_keys_str_mv AT vancegailh improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT lotodoteresa improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT kigennicholas improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT stohlerryan improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT choihaki improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT njugunafestus improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT moormannannm improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT kirwaerastus improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT langatsandra improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT loehrerpatrick improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation
AT vikterry improvementofdiagnosisinchildrenwithburkittlymphomainkenyafeasibilitystudyfortheimplementationoffluorescenceinsituhybridisationtestingformycandthemycightranslocation